Newsfile Corp

IN THE PRESS

Drug Development

RETRANSMISSION: Defence Receives FDA Approval for Phase I Clinical Trial Targeting Solid Cancer Tumors with AccuTOX(R)

December 12, 2023

·

4 min read

FDA

Defence Receives FDA Approval for Phase I Clinical Trial Targeting Solid Cancer Tumors with AccuTOX(R)

December 11, 2023

·

4 min read

ME Therapeutics Holdings Inc. Announces Listing on the Frankfurt Stock Exchange (FSE) and the Completion of Its Redesigned Website

December 11, 2023

·

3 min read

Policy

MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa

December 11, 2023

·

7 min read

Biotech Beach

Skye Bioscience Responds to OTC Markets Promotional Policy

December 11, 2023

·

6 min read

FDA

Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U.S. FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma

December 6, 2023

·

5 min read

Telo Genomics Gears up for American Society of Hematology Conference

December 6, 2023

·

4 min read

Therma Bright Provides Update on Cease Trade Order

December 5, 2023

·

2 min read

Drug Development

Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot

December 5, 2023

·

6 min read

Skye Bioscience and Tautomer Bioscience Enter Exclusive License for SBI-100 for Development and Sale of Products for Chronic Pain and Other Indications in South Africa and Rest of Africa

December 5, 2023

·

8 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750